Parties, docket activity and news coverage of federal case AMGEN INC. et al v. ADELLO BIOLOGICS LLC, case number 2:18-cv-03347, from New Jersey Court.


Jun 15, 2018 ... Amgen Inc., et al. v. Adello Biologics, LLC. Civil Action No. 2:18-cv-03347 (CCC)( MF). Dear Judge Falk: This firm, together with Paul, Weiss, ...


Dec 6, 2018 ... In March this year, Amgen sued Adello Biologics under the BPCIA in the District of New Jersey for infringement of seventeen patents, based on ...


Apr 9, 2018 ... Last month, Amgen sued Adello Biologics, a US-based biosimilar maker, for patent infringement under the Biologics Price Competition and ...


May 29, 2018 ... On March 8, 2018, Amgen Inc. (“Amgen”) filed suit against Adello Biologics, LLC ( “Adello”) ... asserting counterclaims of non-infringement and invalidity for all seventeen patents. Relying on the Supreme Court's Sandoz, Inc. v.


Sep 11, 2017 ... Adello Biologics today announced that U.S. FDA accepted the ... About Adello Biologics LLC. Adello is a ... Neupogen® is a registered trademark of Amgen Inc. ... Search All; Search News; Search Site; Advanced News Search.


Jul 27, 2018 ... ... into the existing consolidated case Onyx Therapeutics, Inc. v. Cipla Limited, et al., the lawsuits that were filed against Dr. Reddy's Laboratories, ... As previously disclosed, Amgen Inc. and Amgen Manufacturing Ltd. (collectively, ... Court for the District of New Jersey against Adello Biologics, LLC (Adello).


Oct 18, 2018 ... Data Engine Technologies LLC v. Google ... Further, Petitioner asserts that a published, double-blind, placebo-controlled clinical trial by Olesen et al. that associated CGRP blockade with ... Adello Biologics, LLC v. Amgen Inc.


Apr 27, 2018 ... Follow-On Biologics Are Set Up to Fail ..... Virtually all states that have passed biologics substitution legislation only allow ...... Amgen Inc. et al v. ..... Adello Biologics' unnamed filgrastim biosimilar, Rixathon/GP2013 (rituximab ...